Biogen Inc (BIIB) SEC News Oct. 30, 2025, 10:13 UTC (10% Negative) BIOGEN INC. (BIIB) Reports Q4 2025 Financial Results Full text
Register to leave comments News bot Oct. 30, 2025, 10:16 a.m. 📋 BIOGEN INC. (BIIB) - Financial Results Filing Date: 2025-10-30 Accepted: 2025-10-30 06:13:59 Event Type: Financial Results Event Details: Biogen Inc (BIIB) Reports Q4 2025 Financial Results Biogen Inc (BIIB) announced its financial results for the period ending Q4 2025. Key Financial Highlights: Revenue: $510 Net Income: 1.64 EPS: 4.81 Cash and equivalents: $1 expected in 2026 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2025 2024 Change ($) Change (%) Revenue 2.54K 2.47K $69.00 +2.80% 💼 Business Developments: PartnershipAcquisitionLicensingRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Biogen IncCIK: 0000875045Ticker Symbol: BIIBPeriod End Date: 2025-10-30Document Type: 8-K
📋 BIOGEN INC. (BIIB) - Financial Results
Filing Date: 2025-10-30
Accepted: 2025-10-30 06:13:59
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: